Jim Griffith

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

The history of echocardiography

Impact of intravascular ultrasound in understanding transplant coronary artery disease

Calcification of the Aortic Arch

Universal Definition of Myocardial Infarction

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Echocardiographic Evaluation of Mitral Valve Structure and Function in Patients Followed for at Least 6 Months After Percutaneous Balloon Mitral Valvuloplasty

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

Percutaneous Repair or Surgery for Mitral Regurgitation

Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer

A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

The changing landscape of atherosclerosis

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Point-of-Care Ultrasonography

A Prospective Natural-History Study of Coronary Atherosclerosis

Accuracy of mitral valve area measurements using transthoracic rapid freehand 3-dimensional scanning: comparison with noninvasive and invasive methods

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Therapeutic dissection after successful coronary balloon angioplasty: No influence on restenosis or on clinical outcome in 693 patients

Diabetes and Atherosclerosis

Burden of valvular heart diseases: a population-based study

Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk

Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: Valve area and right heart disease

Angiographic and clinical outcome following coronary stenting of small vessels

Intracoronary ultrasound imaging: Correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty

Hypertrophic Cardiomyopathy

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Third Universal Definition of Myocardial Infarction

Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients

One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms

Angiographic and intravascular ultrasound predictors of in-stent restenosis

Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

Determinants of coronary compliance in patients with coronary artery disease: An intravascular ultrasound study

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation

Inflammation, Atherosclerosis, and Coronary Artery Disease

Subacute Stent Thrombosis in the Era of Intravascular Ultrasound-Guided Coronary Stenting Without Anticoagulation: Frequency, Predictors and Clinical Outcome

Balloon valvotomy for pregnant patients with severe pliable mitral stenosis using the Inoue technique with total abdominal and pelvic shielding

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Two-Dimensional Real-Time Ultrasonic Imaging of the Heart and Great Vessels

Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction

Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.

Coronary Stenting After Rotational Atherectomy in Calcified and Complex Lesions

Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

Role of Endothelial Dysfunction in Atherosclerosis

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Reliability and reproducibility of two dimensional echocardiographic measurement of the stenotic mitral valve orifice area

Our Preoccupation With Coronary Luminology

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical Implications

Quantitative Assessment of Coronary Vasoreactivity in Humans In Vivo

Clinical Potential of Intravascular Ultrasound for Physiological Assessment of Coronary Stenosis

Histopathologic validation of angioscopy and intravascular ultrasound.

Intravascular Ultrasound

Angiographic Patterns of In-Stent Restenosis

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Clinical End Points in Coronary Stent Trials

Coronary Plaque Disruption

Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.

Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo.

Patterns and Mechanisms of In-Stent Restenosis

Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease.

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.

Determination of Mitral Valve Area by Cross-Sectional Echocardiography

High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults

Treatment of In-Stent Restenosis With Excimer Laser Coronary Angioplasty Versus Rotational Atherectomy

Development of Transplantation Vasculopathy and Progression of Donor-Transmitted Atherosclerosis

Endothelial Function and Dysfunction

Regional contractility. Selective depression of ischemic myocardium by verapamil.

Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro.

Cross-sectional echocardiography in the diagnosis of congenital heart disease. Identification of the relation of the ventricles and great arteries.

Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography.

Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens.